Insider · CIK 0002033000
Dan Drohan
Files at BAER (Bridger Aerospace Group Holdings, Inc.). First filing -, latest -.
In brief
Dan Drohan files SEC Form 4 as director at BAER (Bridger Aerospace Group Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dan Drohan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | BAER Bridger Aerospace Group Holdings, Inc. | AGrant or award Common Stock | +31,708 | $0.00 | $0 | 532,704 | 11 d ago |
| Jun 30, 2026 | BAER Bridger Aerospace Group Holdings, Inc. | AGrant or award Common Stock | +27,514 | $0.00 | $0 | 500,996 | Jul 2, 2026 |
| Jun 4, 2026 | BAER Bridger Aerospace Group Holdings, Inc. | AGrant or award Common Stock | +45,156 | $0.00 | $0 | 473,482 | Jun 8, 2026 |
| Nov 25, 2025 | BAER Bridger Aerospace Group Holdings, Inc. | AGrant or award Common Stock | +154,145 | $0.00 | $0 | 428,326 | Nov 26, 2025 |
Questions about Dan Drohan
Answered from the filings on this page, as of the latest one.
Is Dan Drohan buying or selling?
Dan Drohan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dan Drohan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dan Drohan has 0.
Where does Dan Drohan file Form 4?
Dan Drohan has filed Form 4 at BAER (Bridger Aerospace Group Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.